The US Food and Drug Administration (FDA) has issued draft guidance aimed at enhancing the safety assessment of genome editing…
Read More
The biotech bi-weekly: genome editing, life-extending therapeutics, an early-stage biotech hub and more
The biopharmaceutical and biotechnology sectors have recently experienced an extraordinary period of accelerated activity, marked by a rapid succession of…
Read MoreYOU MAY HAVE MISSED
